专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

51. 发明申请

US20070276009A1 Compositions and Methods for Viral Inhibition 审中-公开
标题翻译：病毒抑制的组合物和方法
公开(公告)号：US20070276009A1
公开(公告)日：2007-11-29
申请号：US10576045
申请日：2004-10-15
申请人： Zhi-Jie Ni , Bryan Chang , Weibo Wang , Amy Weiner
发明人： Zhi-Jie Ni , Bryan Chang , Weibo Wang , Amy Weiner
IPC分类号： A61K31/403 , C07D209/82
CPC分类号： C04B35/632 , C07D209/90 , C07D209/94 , C07D401/12 , C07D405/12 , C07D417/12
摘要： The present invention discloses methods and compositions for viral inhibition, particularly inhibition of HCV and SARS. The invention also provides compositions including carbazole derivatives useful for viral inhibition.
摘要翻译：本发明公开了用于病毒抑制，特别是HCV和SARS抑制的方法和组合物。本发明还提供包含用于病毒抑制的咔唑衍生物的组合物。

52. 发明授权

US09875479B2 Device management apparatus, device management system, and information processing method 有权
公开(公告)号：US09875479B2
公开(公告)日：2018-01-23
申请号：US14735225
申请日：2015-06-10
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： G06F15/16 , G06Q30/00 , H04L12/24 , H04M15/00
CPC分类号： G06Q30/01 , H04L41/12 , H04L41/5032 , H04M15/8016
摘要： A device management apparatus including a receiving unit configured to receive state information indicating a change in a state of a device and store the state information in a state information storage unit; a sending unit configured to send report information relating to the state information to a predetermined destination, when the state information received by the receiving unit corresponds to a report target; and a changing unit configured to expand the report targets when an operation state of the device does not fulfill a scheduled state of a present time point, the operation state being identified based on history of the state information stored in the state information storage unit.

53. 发明授权

US09860105B2 Management device, management method, and recording medium 有权
公开(公告)号：US09860105B2
公开(公告)日：2018-01-02
申请号：US13729845
申请日：2012-12-28
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： G06F15/16 , H04L29/04 , G03G15/00
CPC分类号： H04L29/04 , G03G15/5079 , G03G15/55 , G03G15/553 , G03G2215/00109
摘要： A first acquisition unit acquires an event notification from an MFP and updates first device-status information. A transmission unit transmits the event notification and first reference-destination information. A switching unit switches a first access to the first reference-destination information to a second access to second reference-destination information. A second acquisition unit issues an acquisition request at a first interval, issues an acquisition request at a second interval in response to the event notification, acquires the second device-status information, and update the first device-status information.

54. 发明授权

US09258180B2 Information processing apparatus and computer-readable storage medium 有权
标题翻译：信息处理装置和计算机可读存储介质
公开(公告)号：US09258180B2
公开(公告)日：2016-02-09
申请号：US13751360
申请日：2013-01-28
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： G06F15/167 , H04L12/24 , H04L29/06
CPC分类号： H04L41/00 , H04L41/0226 , H04L63/00 , H04L65/00
摘要： An information processing apparatus is communicable with a device via a first communication channel and communicable with a device management apparatus for managing the device via a second communication channel. The information processing apparatus includes a request generator configured to generate a first device information acquisition request in a second protocol based on a device information acquisition request in a first protocol transmitted from the device management apparatus via the second communication channel; a first transmitter configured to transmit the first device information acquisition request to the device via the first communication channel; a first receiver configured to receive a first device information acquisition response in the second protocol including device information from the device via the first communication channel; and a response generator configured to generate a device information acquisition response in the first protocol based on the first device information acquisition response.
摘要翻译：信息处理设备可经由第一通信信道与设备通信，并且可与用于经由第二通信信道管理设备的设备管理设备通信。所述信息处理装置包括：请求生成器，被配置为基于从所述设备管理装置经由所述第二通信信道发送的第一协议中的设备信息获取请求，生成第二协议中的第一设备信息获取请求; 第一发送器，被配置为经由所述第一通信信道向所述设备发送所述第一设备信息获取请求; 第一接收器，被配置为在所述第二协议中接收第一设备信息获取响应，所述第二协议包括来自所述设备的经由所述第一通信信道的设备信息; 以及响应发生器，被配置为基于所述第一设备信息获取响应在所述第一协议中生成设备信息获取响应。

55. 发明申请

US20130198329A1 INFORMATION PROCESSING APPARATUS AND COMPUTER-READABLE STORAGE MEDIUM 有权
标题翻译：信息处理设备和计算机可读存储介质
公开(公告)号：US20130198329A1
公开(公告)日：2013-08-01
申请号：US13751360
申请日：2013-01-28
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： H04L12/24
CPC分类号： H04L41/00 , H04L41/0226 , H04L63/00 , H04L65/00
摘要： An information processing apparatus is communicable with a device via a first communication channel and communicable with a device management apparatus for managing the device via a second communication channel. The information processing apparatus includes a request generator configured to generate a first device information acquisition request in a second protocol based on a device information acquisition request in a first protocol transmitted from the device management apparatus via the second communication channel; a first transmitter configured to transmit the first device information acquisition request to the device via the first communication channel; a first receiver configured to receive a first device information acquisition response in the second protocol including device information from the device via the first communication channel; and a response generator configured to generate a device information acquisition response in the first protocol based on the first device information acquisition response.
摘要翻译：信息处理设备可经由第一通信信道与设备通信，并且可与用于经由第二通信信道管理设备的设备管理设备通信。所述信息处理装置包括：请求生成器，被配置为基于从所述设备管理装置经由所述第二通信信道发送的第一协议中的设备信息获取请求，生成第二协议中的第一设备信息获取请求; 第一发送器，被配置为经由所述第一通信信道向所述设备发送所述第一设备信息获取请求; 第一接收器，被配置为在所述第二协议中接收第一设备信息获取响应，所述第二协议包括来自所述设备的经由所述第一通信信道的设备信息; 以及响应发生器，被配置为基于所述第一设备信息获取响应在所述第一协议中生成设备信息获取响应。

56. 发明授权

US07504405B2 Mitotic kinesin inhibitors 失效
标题翻译：有丝分裂驱动蛋白抑制剂
公开(公告)号：US07504405B2
公开(公告)日：2009-03-17
申请号：US11100923
申请日：2005-04-06
申请人： Weibo Wang , Ryan Constantine , Liana Lagniton
发明人： Weibo Wang , Ryan Constantine , Liana Lagniton
IPC分类号： C07D487/04 , A61K31/519 , A61P35/00
CPC分类号： C07D471/04 , C07D239/36
摘要： The present invention relates to compounds that are useful for treating cellular proliferative diseases, for treating disorders mediated, at least in part, by KSP, and for inhibiting KSP. The invention also related to pharmaceutical compositions comprising such compounds, methods of treating cancer by the administration of such compositions, and processes for the preparation of the compounds. Compounds of the invention have the following formula:
摘要翻译：本发明涉及可用于治疗细胞增殖性疾病，用于治疗至少部分由KSP介导的病症和用于抑制KSP的化合物。本发明还涉及包含这些化合物的药物组合物，通过施用这些组合物治疗癌症的方法，以及制备化合物的方法。本发明化合物具有下式：

57. 发明申请

US20080312251A1 Aminopyrimidine Compounds and Their Salts, Process for Preparation and Pharmaceutical Use Thereof 有权
标题翻译：氨基嘧啶化合物及其盐，其制备方法及药物用途
公开(公告)号：US20080312251A1
公开(公告)日：2008-12-18
申请号：US11794250
申请日：2005-12-26
申请人： Piaoyang Sun , Aifeng Lv , Baohai Yang , Chunyong Hu , Weibo Wang
发明人： Piaoyang Sun , Aifeng Lv , Baohai Yang , Chunyong Hu , Weibo Wang
IPC分类号： A61K31/506 , C07D401/14 , A61P35/00
CPC分类号： C07D401/14
摘要： The present invention provides aminopyrimidine compounds of formula (I) and their salts, wherein R1, R2, R3, R4, R5, R6, Q, Z, L, m, n are defined as the description, the methods for preparation thereof, the uses thereof and the pharmaceutical compositions comprising the effective amount of compounds of formula (I). The compounds of formula (I) and their salts can be used as protein kinase inhibitors.
摘要翻译：本发明提供式（I）的氨基嘧啶化合物及其盐，其中R1，R2，R3，R4，R5，R6，Q，Z，L，m，n定义为其说明，其制备方法，其用途和包含有效量的式（I）化合物的药物组合物。式（I）化合物及其盐可用作蛋白激酶抑制剂。

58. 发明申请

US20050261337A1 Substituted quinoline derivatives 失效
标题翻译：取代喹啉衍生物
公开(公告)号：US20050261337A1
公开(公告)日：2005-11-24
申请号：US11133509
申请日：2005-05-19
申请人： Weibo Wang , Ryan Constantine , Liana Lagniton , Kenneth Bair
发明人： Weibo Wang , Ryan Constantine , Liana Lagniton , Kenneth Bair
IPC分类号： A61K31/47 , A61K31/4709 , C07D215/12 , C07D215/18 , C07D41/02
CPC分类号： C07D215/12 , C07D215/18
摘要： The present invention relates to new substituted quinoline compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
摘要翻译：本发明涉及新的取代喹啉化合物及其药学上可接受的盐，酯或前药，新化合物与药学上可接受的载体的组合物，以及新化合物的用途。本发明的化合物具有以下通式：

59. 发明申请

US20050215580A1 Tetrahydrocarboline compounds as anticancer agents 失效
标题翻译：四氢咔啉化合物作为抗癌剂
公开(公告)号：US20050215580A1
公开(公告)日：2005-09-29
申请号：US11042474
申请日：2005-01-24
申请人： Weibo Wang , Zhi-Jie Ni , Paul Barsanti , Sabina Pecchi , Yi Xia , Nathan Brammeier , Megan Phillips , Elisa Jazan , Kelly Wayman , David Dibble , Jie-Kai Cheng
发明人： Weibo Wang , Zhi-Jie Ni , Paul Barsanti , Sabina Pecchi , Yi Xia , Nathan Brammeier , Megan Phillips , Elisa Jazan , Kelly Wayman , David Dibble , Jie-Kai Cheng
IPC分类号： A61K31/4745 , C07D471/02 , C07D471/04
CPC分类号： C07D471/04
摘要： Tetrahydrocarboline compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the tetrahydrocarboline compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the tetrahydrocarboline compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
摘要翻译：四氢咔啉化合物，其药学上可接受的盐和前药; 包括药学上可接受的载体和一种或多种四氢咔啉化合物的组合物，单独或与至少一种另外的治疗剂组合。单独使用四氢咔啉化合物或与至少一种另外的治疗剂组合使用的方法可用于预防或治疗增殖性疾病。

60. 发明申请

US20050069555A1 Thiosemicarbazones as anti-virals and immunopotentiators 失效
标题翻译：硫代缩氨基脲作为抗病毒剂和免疫增强剂
公开(公告)号：US20050069555A1
公开(公告)日：2005-03-31
申请号：US10748071
申请日：2003-12-29
申请人： Paul Barsanti , Nathan Brammeier , Anthony Diebes , Liana Lagniton , Simon Ng , Zhi-Jie Ni , Keith Pfister , Casey Philbin , Nicholas Valiante , Allan Wagman , Weibo Wang , Amy Weiner
发明人： Paul Barsanti , Nathan Brammeier , Anthony Diebes , Liana Lagniton , Simon Ng , Zhi-Jie Ni , Keith Pfister , Casey Philbin , Nicholas Valiante , Allan Wagman , Weibo Wang , Amy Weiner
IPC分类号： A61K20060101 , A61K6/00 , A61K31/175 , A61K31/40 , A61K31/44 , A61K39/00 , A61K39/39 , A61P31/12 , C07D207/06 , C07D207/09 , C07D207/14 , C07D207/32 , C07D207/335 , C07D209/14 , C07D209/88 , C07D211/14 , C07D211/18 , C07D211/28 , C07D211/46 , C07D211/56 , C07D211/58 , C07D213/38 , C07D213/40 , C07D213/53 , C07D213/74 , C07D215/12 , C07D217/04 , C07D231/12 , C07D233/24 , C07D235/10 , C07D235/14 , C07D239/48 , C07D241/04 , C07D241/08 , C07D243/08 , C07D277/28 , C07D277/42 , C07D295/096 , C07D295/135 , C07D295/15 , C07D295/155 , C07D295/192 , C07D307/14 , C07D307/52 , C07D307/54 , C07D307/66 , C07D307/79 , C07D307/81 , C07D317/58 , C07D333/68 , C07D401/04 , C07D401/10 , C07D401/12 , C07D401/14 , C07D403/04 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/04 , C07D409/12 , C07D413/10 , C07D413/12 , C07D471/04 , C07D487/04 , C07D487/08 , C07D497/04
CPC分类号： C07D207/335 , A61K31/175 , A61K39/39 , A61K2039/55511 , C07D207/06 , C07D207/09 , C07D207/14 , C07D209/14 , C07D209/88 , C07D211/14 , C07D211/18 , C07D211/28 , C07D211/46 , C07D211/56 , C07D211/58 , C07D213/38 , C07D213/40 , C07D213/53 , C07D213/74 , C07D215/12 , C07D217/04 , C07D231/12 , C07D233/24 , C07D235/14 , C07D239/48 , C07D241/04 , C07D241/08 , C07D243/08 , C07D277/28 , C07D277/42 , C07D295/096 , C07D295/135 , C07D295/15 , C07D295/155 , C07D295/192 , C07D307/14 , C07D307/52 , C07D307/54 , C07D307/66 , C07D307/79 , C07D307/81 , C07D317/58 , C07D333/68 , C07D401/04 , C07D401/10 , C07D401/12 , C07D405/04 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/04 , C07D409/12 , C07D471/04 , C07D487/04 , C07D487/08 , C07D497/04 , A61K2300/00
摘要： The present invention is directed to novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, novel methods for treating viral infections, including HCV, by administering the compounds, and novel methods for modulating an immune response by administering the compounds.
摘要翻译：本发明涉及新型免疫增强剂，新型疫苗佐剂，新化合物和药物组合物，通过施用化合物治疗病毒感染（包括HCV）的新方法，以及通过施用化合物调节免疫应答的新方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式